News

You are here

Sep 10, 2015

From 29/08 to 1/09, Roger Prades, Iproteos CSO, participated at the 28th ECNP Congress of Applied and Translational Neuroscience. His abstract was selected for poster oral presentation, which was given on 30th of August. “It has been a very positive experience. Lots of scientists and physicians came around the poster to know a little bit more about IPR19, the cognitive enhancer we are developing at Iproteos”, has declared Roger after the ECNP Congress.

Sep 10, 2015

Teresa Tarragó will participate at the Innovation Days 2015, a partnering meeting in Open Innovation for Life Sciences. It will take place from 5-6 of October and it is held in Paris. The event features conferences and workshops together with one-to-one partnering meetings. Iproteos CEO will be on Tuesday 6th of October seeking for partnerships and business opportunities. You can know more about our pipeline, and the potential of the IPROTech in this web.

Sep 10, 2015

On 5th of October 2015, Teresa Tarragó, Iproteos CEO, will give the Keynote Lecture at the 2nd CRG BioBusiness School. The 5-day course is aimed to go deep into the Tech Transfer at Science a key aspect in the world of biotech. Participants will learn how to identify projects with potential to be transferred to a company or to create a spin-off. Besides, students will generate their very own business model and will have the opportunity to present it in font of experts that will give them their feedback.

Aug 25, 2015

Teresa Tarragó will attend next Boulder Peptide Symposium 2015 (BPS 2015), which will be held in Denver (Colorado) from 28th September to the 1st of October. Her abstract entitled “IPRO Technology: a platform for the discovery of therapeutic peptidomimetics”, has been selected for the Peptide Showcase, an opportunity to expose the latest and novel ideas, technologies and pipeline assets.

Jul 08, 2015

Roger Prades, Iproteos CSO, will be attending the 28th ECNP Congress of Applied and Translational Neuroscience, which will take place in Amsterdam from the 29th of August till the 1st of September. The good news is that his poster has been selected for a short oral presentation, since his abstract is among the 18 with the highest score. Taking into account that in the previous ECNP Congress, which was held on Berlin, there were more than 5,500 attendees, it is an honor for Iproteos to have been selected for the oral presentation.

Jun 08, 2015

The network ECMED has a brand new webpage (http://www.ecmed-itn.eu). ECMED is a consortium formed by 11 organizations (9 public centres and 2 companies) aimed to design, validate and bring into practice new innovative therapeutic strategies against epilepsy. As well, the consortium seeks to develop a diagnostic approach for the management of this disease. The consortium's projects are co-funded by the European Union’s Horizon 2020 research and innovation programme under a Marie Sklodowska-Curie grant (No. 645881).